Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Prostatic Neoplasms 3Urinary Bladder Neoplasms 2Lung Neoplasms 2Colorectal Neoplasms 2Acute Kidney Injury 2Tuberous Sclerosis 1Spinal Cord Injuries 1Smoldering Multiple Myeloma 1Salivary Gland Adenoma, Pleomorphic 1Renal Insufficiency 1Prostatic Hyperplasia 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Neoplasms, Plasma Cell 1Neoplasms 1Monoclonal Gammopathy of Undetermined Significance 1Lymphangioleiomyomatosis 1Gallbladder Neoplasms 1Disease 1Cholangiocarcinoma 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Microarray Analysis 2In Situ Hybridization, Fluorescence 2Cytogenetic Analysis 2Biopsy 2Watchful Waiting 1Urination 1Tissue Banks 1Surveys and Questionnaires 1Radioimmunodetection 1Molecular Diagnostic Techniques 1Immunohistochemistry 1Fentanyl 1Blood Specimen Collection 1Absorptiometry, Photon 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Monoclonal Gammopathy of Undetermined Significance × Urination × Clear all
NCT03951220 2025-08-19

LOOMIS

Oxford University Hospitals NHS Trust

Completed
67 enrolled 24 charts
Plasma cell

Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡